MedTrace Logo

Baerveldt Versus Paul Study

NCT07733453 · Status: NOT_YET_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2026-08-03

No results posted yet for this study

Summary

The Baerveldt Versus Paul (BvP) Study is a Registry-based Randomised Controlled Trial, Comparing the Baerveldt Glaucoma Implant (BGI) and the Paul Glaucoma Implant (PGI). Participants will Include patients requiring aqueous shunt surgery for control of intraocular pressure and glaucoma.

The objective of this study is to compare the long-term safety and effectiveness of placement of a BGI and PGI for patients who are undergoing aqueous shunt implant surgery. Patients who qualify for the study are randomized to receive either a BGI or PGI aqueous shunt.

Conditions

Interventions

DEVICE

Baerveldt Glaucoma Implant

Surgical insertion of an aqueous shunt for control of intraocular pressure and/or glaucoma

DEVICE

Paul Glaucoma Implant

Surgical insertion of an aqueous shunt for control of intraocular pressure and/or glaucoma

Sponsors & Collaborators

  • University of Sydney

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-10-12
Primary Completion
2033-04-30
Completion
2033-04-30

Countries

  • Australia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07733453 on ClinicalTrials.gov